Multiple System Atrophy

Primer on the Autonomic Nervous System

Volumn , Issue , 2012, Pages 453-457

  Robertson, David W ^a   Gilman, Sid ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b Department of Neurology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864211698     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-386525-0.00093-7     Document Type: Chapter

References (16)

1. Bower JH, Maraganore DM, McDonnell SK, et al. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997, 49:1284-1288.
2. Chrysostome V, Tison F, Yekhlef F, et al. Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology 2004, 23:201-208.
3. Danzer KM, Krebs SK, Wolff M, et al. Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem 2009, 111:192-203.
4. Fowler CJ, O'Malley KJ Investigation and management of neurogenic bladder dysfunction. J Neurol Neurosurg Psychiatry 2003, 74(Suppl. 4):iv27-iv31.
5. Freeman R Current pharmacologic treatment for orthostatic hypotension. Clin Auton Res 2008, 18(Suppl. 1):14-18.
6. Gilman S, Little R, Johanns J, et al. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology 2000, 55:527-532.
7. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71:670-676.
8. Hsu LJ, Sagara Y, Arroyo A, et al. alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 2000, 157:401-410.
9. Kahle PJ, Neumann M, Ozmen L, et al. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 2002, 3:583-588.
10. Lindersson E, Lundvig D, Petersen C, et al. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem 2005, 280:5703-5715.
11. Luk KC, Song C, O'Brien P, et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci USA 2009, 106:20051-20056.
12. Raffel DM, Koeppe RA, Little R, et al. PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. J Nucl Med 2006, 47:1769-1777.
13. Scholz SW, Houlden H, Schulte C, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009, 65:610-614.
14. Stefanova N, Poewe W, Wenning GK Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Exp Neurol 2008, 210:421-427.
15. Ubhi K, Rockenstein E, Mante M, et al. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy. Neuroreport 2008, 19:1271-1276.
16. Winner B, Jappelli R, Maji SK, et al. In vivo demonstration that α-synuclein oligomers are toxic. Proc Natl Acad Sci USA 2011, 108:4194-4199.